S. Bordow

Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma.

M. Haber, M. Norris, G. Marshall, 1994, Cancer research.

Use of tumor-specific gene expression for the differential diagnosis of neuroblastoma from other pediatric small round-cell malignancies.

M. Haber, M. Norris, G. Marshall, 1999, The American journal of pathology.

Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma.

S. Cohn, P. Haber, M. Haber, 1996, The New England journal of medicine.

Altered expression of the MYCN oncogene modulates MRP gene expression and response to cytotoxic drugs in neuroblastoma cells

M. Kavallaris, M. Haber, M. Norris, 1999, Oncogene.

Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma.

D. Hipfner, S. Cohn, M. Kavallaris, 1997, European journal of cancer.

Prognostic significance of MYCN oncogene expression in childhood neuroblastoma.

P. Haber, M. Haber, M. Norris, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The prognostic value of MDR1 gene expression in primary untreated neuroblastoma.

B. Stewart, P. Haber, M. Haber, 1997, European journal of cancer.

Expression of retinoic acid-responsive genes in primary neuroblastomas.

M. Haber, M. Norris, B. Cheung, 1994, Progress in clinical and biological research.